Cargando…
Adjunct rasagiline to treat Parkinson’s disease with motor fluctuations: a randomized, double-blind study in China
BACKGROUND: The use of adjunct rasagiline in levodopa-treated patients with Parkinson’s disease and motor fluctuations is supported by findings from large-scale clinical studies. This study is to investigate the efficacy and safety of adjunct rasagiline in Chinese patients with Parkinson’s disease,...
Autores principales: | Zhang, Zhenxin, Shao, Ming, Chen, Shengdi, Liu, Chunfeng, Peng, Rong, Li, Yansheng, Wang, Jian, Zhu, Suiqiang, Qu, Qiumin, Zhang, Xiaoying, Chen, Haibo, Sun, Xiangru, Wang, Yanping, Sun, Shenggang, Zhang, Baorong, Li, Jimei, Pan, Xiaoping, Zhao, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026338/ https://www.ncbi.nlm.nih.gov/pubmed/29988514 http://dx.doi.org/10.1186/s40035-018-0119-7 |
Ejemplares similares
-
Efficacy and safety of rasagiline in Chinese patients with early Parkinson’s disease: a randomized, double-blind, parallel, placebo-controlled, fixed-dose study
por: Zhang, Zhenxin, et al.
Publicado: (2018) -
Adjunctive therapy in Parkinson’s disease: the role of rasagiline
por: Gaines, Kathryn D, et al.
Publicado: (2012) -
Rasagiline as Adjunct to Levodopa for Treatment of Parkinson's Disease: A Systematic Review and Meta-Analysis
por: Kano, Osamu, et al.
Publicado: (2022) -
The efficacy and safety of pramipexole ER versus IR in Chinese patients with Parkinson’s disease: a randomized, double-blind, double-dummy, parallel-group study
por: Wang, Ying, et al.
Publicado: (2014) -
Long-term safety and efficacy of adjunctive rasagiline in levodopa-treated Japanese patients with Parkinson’s disease
por: Hattori, Nobutaka, et al.
Publicado: (2019)